Avidity Biosciences
RNAM
#1865
Rank
NZ$20.21 B
Marketcap
NZ$130.89
Share price
0.00%
Change (1 day)
47.03%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: NZ$20.21 Billion

As of November 2026 Avidity Biosciences has a market cap of NZ$20.21 Billion. This makes Avidity Biosciences the world's 1865th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$301.71 B 1,392.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$182.30 B 801.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.21 B-84.10%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.74 B-51.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.35 B-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.47 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$19.64 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$6.92 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA